Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News PetVivo Holdings Inc (QX) PETV

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company’s lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices... see more

Recent & Breaking News (OTCQX:PETV)

UPDATED: PetVivo AI, Inc. Launches AI Platform Reducing Veterinary Client Acquisition Costs by 50-90%

GlobeNewswire 11 days ago

PetVivo Launches AI Platform Reducing Veterinary Client Acquisition Costs by 50-89%

GlobeNewswire 12 days ago

PetVivo Holdings Announces Digital Landia's Publication of Technical Whitepaper Validating AgenticPet AI Framework Under Exclusive 10-Year Licensing Agreement

GlobeNewswire November 17, 2025

PetVivo Reports Fiscal Q2 2026 Results with Revenues up 50%

GlobeNewswire November 14, 2025

PetVivo Sets Fiscal Second Quarter 2026 Conference Call for Friday, November 14, 2025 at 5:00 p.m. ET

GlobeNewswire November 7, 2025

Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors

GlobeNewswire October 28, 2025

PetVivo Holdings, Inc. Addresses Veterinary Industry's GEN Z Problem With Breakthrough AI License Agreement

GlobeNewswire October 21, 2025

PetVivo Animal Health, Inc. Enters Vendor Partner Agreement with Veterinary Growth Partners to Expand Access to Innovative Veterinary Therapeutics

GlobeNewswire October 16, 2025

PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF NOTE CONVERSION AGREEMENTS TO EXTINGUISH OVER TWO MILLION DOLLARS OF OUTSTANDING DEBT

GlobeNewswire September 30, 2025

PetVivo Animal Health Expands Veterinary Education with New RACE-Approved CE Courses on Osteoarthritis and Regenerative Therapies

GlobeNewswire September 25, 2025

PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH NUPSALA LIMITED

GlobeNewswire September 2, 2025

PetVivo Reports Fiscal Q1 2026 Results

GlobeNewswire August 14, 2025

PetVivo Sets Fiscal First Quarter 2026 Conference Call for Thursday, August 14, 2025 at 5:00 p.m. ET

GlobeNewswire August 7, 2025

PetVivo Holdings Inc. to Trade on OTCQX Best Market

GlobeNewswire July 30, 2025

OTC Markets Group Welcomes PetVivo Holdings Inc. to OTCQX

GlobeNewswire July 30, 2025

PetVivo Reports Fiscal 2025 Results

GlobeNewswire June 30, 2025

PetVivo Sets Fiscal Fourth Quarter 2025 Conference Call for Monday, June 30 at 5:00 p.m. ET

GlobeNewswire June 26, 2025

PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING

GlobeNewswire June 24, 2025

PETVIVO HOLDINGS, INC. ANNOUNCES INVESTOR EXERCISE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING

GlobeNewswire June 20, 2025

PetVivo and Commonwealth Partner to Advance Equine Wellness Across Thoroughbred Racing

GlobeNewswire June 6, 2025